Literature DB >> 26068728

Cocaine and Amphetamine Induce Overlapping but Distinct Patterns of AMPAR Plasticity in Nucleus Accumbens Medium Spiny Neurons.

Jakub Jedynak1, Matthew Hearing1, Anna Ingebretson1, Stephanie R Ebner1, Matthew Kelly1, Rachel A Fischer1, Saïd Kourrich1, Mark J Thomas1,2.   

Abstract

Repeated exposure to psychostimulant drugs such as cocaine or amphetamine can promote drug-seeking and -taking behavior. In rodent addiction models, persistent changes in excitatory glutamatergic neurotransmission in the nucleus accumbens (NAc) appear to drive this drug-induced behavioral plasticity. To study whether changes in glutamatergic signaling are shared between or exclusive to specific psychostimulant drugs, we examined synaptic transmission from mice following repeated amphetamine or cocaine administration. Synaptic transmission mediated by AMPA-type glutamate receptors was potentiated in the NAc shell 10-14 days following repeated amphetamine or cocaine treatment. This synaptic enhancement was depotentiated by re-exposure to amphetamine or cocaine. By contrast, in the NAc core only repeated cocaine exposure enhanced synaptic transmission, which was subsequently depotentiated by an additional cocaine but not amphetamine injection during drug abstinence. To better understand the drug-induced depotentiation, we replicated these in vivo findings using an ex vivo model termed 'challenge in the bath,' and showed that drug-induced decreases in synaptic strength occur rapidly (within 30 min) and require activation of metabotropic glutamate receptor 5 (mGluR5) and protein synthesis in the NAc shell, but not NAc core. Overall, these data demonstrate the specificity of neuronal circuit changes induced by amphetamine, introduce a novel method for studying drug challenge-induced plasticity, and define NAc shell medium spiny neurons as a primary site of persistent AMPA-type glutamate receptor plasticity by two widely used psychostimulant drugs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26068728      PMCID: PMC5130122          DOI: 10.1038/npp.2015.168

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  81 in total

Review 1.  Exciting inhibition in psychostimulant addiction.

Authors:  Peter W Kalivas; Xiu-Ti Hu
Journal:  Trends Neurosci       Date:  2006-09-07       Impact factor: 13.837

2.  Relapse to cocaine-seeking increases activity-regulated gene expression differentially in the striatum and cerebral cortex of rats following short or long periods of abstinence.

Authors:  M C Hearing; R E See; J F McGinty
Journal:  Brain Struct Funct       Date:  2008-05-17       Impact factor: 3.270

3.  Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization.

Authors:  R C Pierce; K Bell; P Duffy; P W Kalivas
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

4.  Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse.

Authors:  Khaled Moussawi; Wenhua Zhou; Haowei Shen; Carmela M Reichel; Ronald E See; David B Carr; Peter W Kalivas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

5.  Cocaine effects in the ventral tegmental area: evidence for an indirect dopaminergic mechanism of action.

Authors:  M S Brodie; T V Dunwiddie
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

6.  Role of p/q-Ca2+ channels in metabotropic glutamate receptor 2/3-dependent presynaptic long-term depression at nucleus accumbens synapses.

Authors:  David Robbe; Gerard Alonso; Severine Chaumont; Joel Bockaert; Olivier J Manzoni
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

7.  Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens.

Authors:  C J Xue; J P Ng; Y Li; M E Wolf
Journal:  J Neurochem       Date:  1996-07       Impact factor: 5.372

8.  The role of glutamate receptor redistribution in locomotor sensitization to cocaine.

Authors:  Carrie R Ferrario; Xuan Li; Xiaoting Wang; Jeremy M Reimers; Jamie L Uejima; Marina E Wolf
Journal:  Neuropsychopharmacology       Date:  2009-11-18       Impact factor: 7.853

9.  AMPAR-independent effect of striatal αCaMKII promotes the sensitization of cocaine reward.

Authors:  Saïd Kourrich; Jason R Klug; Mark Mayford; Mark J Thomas
Journal:  J Neurosci       Date:  2012-05-09       Impact factor: 6.167

Review 10.  Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems.

Authors:  B J Everitt; J A Parkinson; M C Olmstead; M Arroyo; P Robledo; T W Robbins
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

View more
  20 in total

1.  Reversal of morphine-induced cell-type-specific synaptic plasticity in the nucleus accumbens shell blocks reinstatement.

Authors:  Matthew C Hearing; Jakub Jedynak; Stephanie R Ebner; Anna Ingebretson; Anders J Asp; Rachel A Fischer; Clare Schmidt; Erin B Larson; Mark John Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-06       Impact factor: 11.205

2.  Estrous cycle-induced sex differences in medium spiny neuron excitatory synaptic transmission and intrinsic excitability in adult rat nucleus accumbens core.

Authors:  Stephanie B Proaño; Hannah J Morris; Lindsey M Kunz; David M Dorris; John Meitzen
Journal:  J Neurophysiol       Date:  2018-06-27       Impact factor: 2.714

3.  Synaptic Depotentiation and mGluR5 Activity in the Nucleus Accumbens Drive Cocaine-Primed Reinstatement of Place Preference.

Authors:  Michael A Benneyworth; Matthew C Hearing; Anders J Asp; Aric Madayag; Anna E Ingebretson; Clare E Schmidt; Keelia A Silvis; Erin B Larson; Stephanie R Ebner; Mark J Thomas
Journal:  J Neurosci       Date:  2019-04-04       Impact factor: 6.167

Review 4.  Metaplasticity at the addicted tetrapartite synapse: A common denominator of drug induced adaptations and potential treatment target for addiction.

Authors:  Daniela Neuhofer; Peter Kalivas
Journal:  Neurobiol Learn Mem       Date:  2018-02-09       Impact factor: 2.877

5.  Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine.

Authors:  Kathryn D Fischer; Alex C W Houston; Rajeev I Desai; Michelle R Doyle; Jack Bergman; Maha Mian; Rebekah Mannix; David L Sulzer; Se Joon Choi; Eugene V Mosharov; Nathaniel W Hodgson; Anita Bechtholt; Klaus A Miczek; Paul A Rosenberg
Journal:  Psychopharmacology (Berl)       Date:  2018-02-22       Impact factor: 4.530

6.  Methamphetamine self-administration modulates glutamate neurophysiology.

Authors:  Devesh Mishra; Jose Ignacio Pena-Bravo; Kah-Chung Leong; Antonieta Lavin; Carmela M Reichel
Journal:  Brain Struct Funct       Date:  2016-10-05       Impact factor: 3.270

7.  Suppression of inhibitory G protein signaling in forebrain pyramidal neurons triggers plasticity of glutamatergic neurotransmission in the nucleus accumbens core.

Authors:  Ezequiel Marron Fernandez de Velasco; Nicholas Carlblom; Zhilian Xia; Kevin Wickman
Journal:  Neuropharmacology       Date:  2017-01-25       Impact factor: 5.250

8.  Engineered D2R Variants Reveal the Balanced and Biased Contributions of G-Protein and β-Arrestin to Dopamine-Dependent Functions.

Authors:  Samuel J Rose; Thomas F Pack; Sean M Peterson; Kaitlin Payne; Emiliana Borrelli; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2017-10-25       Impact factor: 7.853

Review 9.  Homeostatic regulation of reward via synaptic insertion of calcium-permeable AMPA receptors in nucleus accumbens.

Authors:  Kenneth D Carr
Journal:  Physiol Behav       Date:  2020-02-21

10.  Cocaine Experience Enhances Thalamo-Accumbens N-Methyl-D-Aspartate Receptor Function.

Authors:  Max E Joffe; Brad A Grueter
Journal:  Biol Psychiatry       Date:  2016-04-07       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.